法国全国调查:CKD患者(含肾衰竭)的健康感知与生活质量
该横断面研究纳入2693例中晚期CKD门诊患者、1658例 functioning 肾移植受者、1251例维持性透析患者及20574例一般人群代表,评估不同CKD分期与HRQoL生理和心理维度的关联。年龄性别标准化后,中晚期CKD和透析患者自评健康差或一般的比例远高于一般人群,所有CKD亚组生理评分均显著低于一般人群,仅透析患者心理评分差异超过最小临床重要差异。
要点
- 中晚期CKD及透析患者自评健康差或一般的比例显著高于一般人群。
- 所有CKD亚组生理HRQoL评分均显著低于一般人群。
- 仅透析患者心理HRQoL评分差异超过最小临床重要差异。
核心结论
- CKD患者即使未进展至肾衰竭,其感知生理健康也显著低于一般人群,需更关注CKD相关生活质量。
研究设计与样本
- 横断面研究,纳入2693例中晚期CKD门诊患者、1658例 functioning 肾移植受者、1251例维持性透析患者及20574例一般人群代表。
主要发现
- 年龄性别标准化后,自评健康差或一般的比例:中度CKD为27%,晚期CKD或透析>40%, functioning 移植为12%,一般人群为3%。
- 调整年龄、性别、教育、肥胖和糖尿病后,所有CKD亚组生理评分均显著低于一般人群。
- 透析患者生理评分与一般人群差异超过4.5分(该研究的最小临床重要差异),晚期CKD和移植受者差异接近该阈值。
- 仅透析患者心理评分与一般人群差异超过最小临床重要差异。
关键数值与推荐
- 中度CKD定义:stage 3,eGFR 30-60mL/min/1.73m2。
- 晚期CKD定义:stages 4-5,eGFR<30mL/min/1.73m2,未接受肾脏替代治疗。
- 生理评分最小临床重要差异为4.5分。
临床怎么用
- 肾内科应常规关注CKD患者(包括未透析者)的生理健康相关生活质量。
- 对透析患者需同时评估心理和生理HRQoL。
局限性
- 各亚组均为横断面设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Health-related quality of life (HRQoL) is a major outcome measure increasingly used in patients with chronic kidney disease (CKD). We evaluated the association between different stages of CKD and the physical and mental health domains of HRQoL. STUDY DESIGN: Cross-sectional study. SETTING & PARTICIPANTS: 2,693 outpatients with moderate (stage 3, estimated glomerular filtration rate [eGFR], 30-60mL/min/1.73m2) or advanced (stages 4-5, estimated glomerular filtration rate<30mL/min/1.73m2, not on kidney replacement therapy [KRT]) CKD under the care of a nephrologist at 1 of 40 nationally representative facilities, 1,658 patients with a functioning kidney transplant, 1,251 patients on maintenance dialysis randomly selected from the national Renal Epidemiology and Information Network registry, and 20,574 participants in the French Decennial Health Survey, representative of the general population. PREDICTOR: Severity of kidney disease (moderate CKD, advanced CKD, maintenance dialysis as KRT, and functioning kidney transplant as KRT), compared with a sample of the general population. OUTCOMES: HRQoL scores assessed using the Medical Outcomes Study 36-Item Short Form Health Survey or the Kidney Disease Quality of Life 36 scale. ANALYTICAL APPROACH: Age- and sex-standardized (to the general population) prevalence of poor or fair health status was estimated for each study kidney disease group. Analysis of variance was used to estimate adjusted differences in mean physical and mental health scores between the kidney disease subgroups and the general population. RESULTS: Mean age was 67.2±12.6 (SD) years for patients with non-KRT-requiring CKD, 69.3±17.7 years for dialysis patients, and 55.3±14.2 years for those with functioning kidney transplants; 60% were men. Age- and sex-standardized health status was perceived as fair or poor in 27% of those with moderate CKD,>40% of those with advanced CKD or receiving dialysis, 12% with a functioning transplant, and 3% of the general population sample. HRQoL physical scores (adjusted for age, sex, education, obesity, and diabetes) were significantly lower in patients in all CKD subgroups than in the general population. For patients receiving dialysis, the magnitude of the difference in physical score versus the general population exceeded 4.5 points, the minimal clinically important difference for this score in this study; for both kidney transplant recipients and patients with advanced CKD, the magnitude of the difference was close to this threshold. For mental score, only dialysis patients had a score that differed from that of the general population by more than the minimal clinically important difference. LIMITATIONS: Cross-sectional study design for each subpopulation. CONCLUSIONS: This study highlights the degree to which perceived physical health is lower in the setting of CKD than in the general population, even in the absence of kidney failure, and calls for greater attention to CKD-related quality of life.
引用
- Legrand K, Speyer E, Stengel B, et al. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France. Am J Kidney Dis. 2019. PMID: 31879215. doi:10.1053/j.ajkd.2019.08.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。